Your browser doesn't support javascript.
loading
Developing new drugs that activate the protective arm of the renin-angiotensin system as a potential treatment for respiratory failure in COVID-19 patients.
Latil, Mathilde; Camelo, Serge; Veillet, Stanislas; Lafont, René; Dilda, Pierre J.
Affiliation
  • Latil M; Biophytis, Sorbonne Université - BC9, 4 Place Jussieu, 75005 Paris, France.
  • Camelo S; Biophytis, Sorbonne Université - BC9, 4 Place Jussieu, 75005 Paris, France.
  • Veillet S; Biophytis, Sorbonne Université - BC9, 4 Place Jussieu, 75005 Paris, France.
  • Lafont R; Biophytis, Sorbonne Université - BC9, 4 Place Jussieu, 75005 Paris, France; Sorbonne Université, CNRS - Institut de Biologie Paris Seine (BIOSIPE), 75005 Paris, France.
  • Dilda PJ; Biophytis, Sorbonne Université - BC9, 4 Place Jussieu, 75005 Paris, France. Electronic address: pierre.dilda@biophytis.com.
Drug Discov Today ; 26(5): 1311-1318, 2021 05.
Article in En | MEDLINE | ID: mdl-33609783

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas Main subject: Renin-Angiotensin System / SARS-CoV-2 / COVID-19 Drug Treatment Language: En Journal: Drug Discov Today Year: 2021 Type: Article Affiliation country: France

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas Main subject: Renin-Angiotensin System / SARS-CoV-2 / COVID-19 Drug Treatment Language: En Journal: Drug Discov Today Year: 2021 Type: Article Affiliation country: France